The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olanzapine (OLN) versus aprepitant (APR) in patients receiving high-emetogenic chemotherapy: Final results of randomized phase II trial.
 
Alexey Rumyantsev
No Relationships to Disclose
 
Elena Glazkova
No Relationships to Disclose
 
Rukhshona Nasyrova
No Relationships to Disclose
 
Ekaterina Ignatova
No Relationships to Disclose
 
Lia Chitia
No Relationships to Disclose
 
Anna Popova
No Relationships to Disclose
 
Dzhennet Chekini
No Relationships to Disclose
 
Yaroslava Kochetkova
No Relationships to Disclose
 
Sergei Kit
No Relationships to Disclose
 
Kheda Elsnukaeva
No Relationships to Disclose
 
Sophia Menshikova
No Relationships to Disclose
 
Olga Sekhina
No Relationships to Disclose
 
Ilya Pokataev
Speakers' Bureau - AstraZeneca; BioCad; Roche; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; BioCad; Roche; Roche
 
Alexandra Tyulyandina
Speakers' Bureau - AstraZeneca; BioCad; Pfizer (I); Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Marina Stenina
Honoraria - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Mona A. Frolova
Honoraria - MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; MSD; Novartis; Roche
Research Funding - MSD; Roche
Travel, Accommodations, Expenses - Roche
 
Anatoly Bulanov
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose
 
Alexey Tryakin
Consulting or Advisory Role - BioCad; Bristol-Myers Squibb; Eisai; Roche/Genentech
Speakers' Bureau - Amgen; Bayer Health; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; Sanofi
Travel, Accommodations, Expenses - Bayer; BioCad; Novartis; Veropharm
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Speakers' Bureau - AstraZeneca; BioCad; Lilly; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Roche